Marker Therapeutics Files 8-K on Shareholder Votes & Financials
Ticker: MRKR · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1094038
| Field | Detail |
|---|---|
| Company | Marker Therapeutics, Inc. (MRKR) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting, sec-filing
TL;DR
Marker Therapeutics filed an 8-K on June 9th covering shareholder votes and financials from June 6th.
AI Summary
Marker Therapeutics, Inc. filed an 8-K on June 9, 2025, reporting on matters submitted to a vote of security holders and financial statements. The filing pertains to events occurring on June 6, 2025. The company, formerly known as TAPIMMUNE INC. and GENEMAX CORP, is incorporated in Delaware and headquartered in Houston, Texas.
Why It Matters
This 8-K filing provides updates on corporate governance and financial reporting, which are crucial for investors to assess the company's operational status and strategic decisions.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting on standard corporate events and does not indicate any immediate material changes or risks.
Key Players & Entities
- Marker Therapeutics, Inc. (company) — Registrant
- TAPIMMUNE INC. (company) — Former Company Name
- GENEMAX CORP (company) — Former Company Name
- June 6, 2025 (date) — Date of earliest event reported
- June 9, 2025 (date) — Filing Date
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not elaborated upon in the provided text.
What financial statements are included in this 8-K filing?
The filing states that 'Financial Statements and Exhibits' are included, but the specific financial statements are not detailed in the provided excerpt.
When was Marker Therapeutics, Inc. previously known as TAPIMMUNE INC.?
Marker Therapeutics, Inc. was formerly known as TAPIMMUNE INC. with a date of name change on June 29, 2017.
What is the Standard Industrial Classification (SIC) code for Marker Therapeutics, Inc.?
The SIC code for Marker Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Where is Marker Therapeutics, Inc. headquartered?
Marker Therapeutics, Inc. is headquartered in Houston, Texas, with its business address listed as 2450 Holcombe Blvd, Suite BCM-A, MS: BCM251.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding Marker Therapeutics, Inc. (MRKR).